Core Viewpoint - Tianzhihang (688277) has experienced significant stock price fluctuations, with a recent increase of 27.67% to 22.93 yuan, reaching a near one-year high of 26.26 yuan on January 14, 2026, while facing a delay in its "Smart Medical Center Construction Project" due to industry cyclicality and regulatory adjustments [1][2][4] Trading Information Summary - Tianzhihang's stock price has shown abnormal volatility, with a cumulative price deviation exceeding 30% over three consecutive trading days, leading to its appearance on the "Dragon and Tiger List" twice in the past five trading days [1][4] - The company reported a total market capitalization of 10.456 billion yuan, ranking 38th in the medical device sector and 1967th among all A-shares [1] Company Announcement Summary - The "Smart Medical Center Construction Project" has been postponed from June 2026 to December 2027 due to industry cyclicality, regulatory policy adjustments, and a slowdown in hospital procurement [2][4] - The project’s funding purpose, total investment amount, and implementing entity remain unchanged, and the delay has been approved by the company's board of directors [2][4]

Core Viewpoint - The company announced a delay in the "Smart Medical Center Construction Project" while maintaining the original investment purpose, total investment amount, and implementation entity, ensuring no substantial adverse impact on the project [1][4][7]. Fundraising Overview - The company raised a total of RMB 370,199,990.23 by issuing 29,545,091 shares at a price of RMB 12.53 per share, with a net amount of RMB 359,756,594.00 after deducting underwriting fees [1][3]. - The funds are managed in a dedicated account as per regulations to protect investor rights [2]. Project Status and Delay Reasons - The project is focused on three main areas: remote collaboration platform construction, operational platform upgrades, and data-based analysis applications [5]. - The delay is attributed to objective factors such as industry cyclical fluctuations and regulatory policy adjustments, which have slowed down procurement decisions and project approvals in the downstream hospital sector [6]. - The company has adjusted its investment pace to ensure project quality and efficiency, postponing the project completion date to December 2027 [6][7]. Approval Process - The board of directors approved the project delay on January 9, 2026, and the sponsor, CITIC Securities, provided a no-objection opinion, indicating that no shareholder meeting was required for this decision [8][9].